Carl Goldfischer insider trades: Epizyme (EPZM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Carl reports to the SEC
and 4 more companies
Open-market buys and sales
30 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 11, 2020 | EPZM | ↑ Buy | 5,000 | $12.07 | $60K | Direct | Nov 13, 2020 (2d) |
| Feb 7, 2019 | CBAY | ↓ Sell | 11,675 | $9.02 | $105K | Direct | Feb 8, 2019 (1d) |
| Mar 22, 2018 | CBAY | ↓ Sell | 15,000 | $13.03 | $195K | Direct | Mar 23, 2018 (1d) |
| Nov 2, 2017 | CBAY | ↓ Sell | 18,000 | $8.66 | $156K | Direct | Nov 6, 2017 (4d) |
| May 25, 2017 | ETRM | ↓ Sell | 4,668 | $4.85 | $23K | Indirect | May 26, 2017 (1d) |
| Jan 12, 2016 | EPZM | ↑ Buy | 555,555 | $9.00 | $5.0M | Indirect | Jan 12, 2016 (0d) |
| Sep 11, 2015 | CBAY | ↓ Sell | 43,824 | $2.74 | $120K | By The Bay City Capital Fund II, L.P. | Sep 11, 2015 (0d) |
| Sep 11, 2015 | CBAY | ↓ Sell | 2,864 | $2.74 | $8K | By The Bay City Capital Fund II Co-Inves | Sep 11, 2015 (0d) |
| Sep 11, 2015 | CBAY | ↓ Sell | 41 | $2.74 | $113 | By Bay City Capital LLC | Sep 11, 2015 (0d) |
| Sep 4, 2014 | EPZM | ↓ Sell | 4,000 | $35.14 | $141K | Indirect | Sep 5, 2014 (1d) |
| Aug 26, 2014 | EPZM | ↓ Sell | 200,000 | $35.14 | $7.0M | Indirect | Aug 28, 2014 (2d) |
| Aug 25, 2014 | EPZM | ↓ Sell | 366,666 | $33.98 | $12.5M | Indirect | Aug 25, 2014 (0d) |
| Feb 10, 2014 | EPZM | ↓ Sell | 466,667 | $29.25 | $13.7M | Indirect | Feb 12, 2014 (2d) |
| Jun 5, 2013 | EPZM | ↑ Buy | 166,666 | $15.00 | $2.5M | Indirect | Jun 7, 2013 (2d) |
| Sep 23, 2011 | ETRM | ↑ Buy | 840,000 | $1.65 | $1.4M | See below | Sep 26, 2011 (3d) |
| Dec 14, 2010 | ETRM | ↑ Buy | 1,700,000 | $1.74 | $3.0M | See below | Dec 16, 2010 (2d) |
| Mar 16, 2010 | MAPP | ↓ Sell | 262,786 | $16.21 | $4.3M | Indirect | Mar 16, 2010 (0d) |
| Mar 11, 2010 | MAPP | ↓ Sell | 339,914 | $15.80 | $5.4M | Indirect | Mar 11, 2010 (0d) |
| Feb 19, 2009 | ETRM | ↑ Buy | 1,649,485 | $1.15 | $1.9M | See below | Feb 20, 2009 (1d) |
| Oct 24, 2008 | ETRM | ↑ Buy | 49,600 | $1.10 | $55K | See below | Oct 28, 2008 (4d) |
| Apr 29, 2008 | ETRM | ↑ Buy | 25,000 | $4.50 | $113K | See below | Apr 30, 2008 (1d) |
| Apr 24, 2008 | ETRM | ↑ Buy | 50,000 | $4.50 | $225K | See below | Apr 28, 2008 (4d) |
| Feb 29, 2008 | ETRM | ↑ Buy | 20,990 | $8.66 | $182K | See below | Mar 4, 2008 (4d) |
| Nov 15, 2007 | ETRM | ↑ Buy | 375,000 | $8.00 | $3.0M | See below | Nov 19, 2007 (4d) |
| Aug 30, 2007 | PARD | ↑ Buy | 3,712 | $5.90 | $22K | Indirect | Aug 31, 2007 (1d) |
| Aug 29, 2007 | PARD | ↑ Buy | 244 | $5.75 | $1K | Indirect | Aug 31, 2007 (2d) |
| Aug 16, 2007 | PARD | ↑ Buy | 256 | $5.49 | $1K | Indirect | Aug 16, 2007 (0d) |
| Aug 10, 2007 | PARD | ↑ Buy | 675 | $5.50 | $4K | Indirect | Aug 14, 2007 (4d) |
| Apr 30, 2007 | PARD | ↑ Buy | 55,227 | $6.33 | $350K | Indirect | Apr 30, 2007 (0d) |
| Apr 26, 2006 | NERX | ↑ Buy | 1,244,935 | $0.70 | $871K | Indirect | Apr 28, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Carl Goldfischer's insider trades
Carl Goldfischer is a director at Epizyme (EPZM). Since Apr 26, 2006, Carl has reported 17 open-market purchases worth $18.6M and 13 sales worth $43.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (52 filings), conversions (7 filings), other transactions (7 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EPZM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.